Contact us
Please fill out the details below and we will get back to you shortly.
Thank you!
We will be contacting you soon..
Close
We will be contacting you soon..
Oops! Something went wrong while submitting the form.
October 2024 - At the Partnership Opportunities in Drug Delivery (PODD) conference, Robert Hidalgo showcased Portal Instrument's latest advancements on its reusable, electro-mechanical drug delivery platform.
Boston, MA – October 27, 2024– Portal Instruments, a leader in innovative drug delivery technology, presented its latest advancements in its drug delivery injection systems at the Partnership Opportunities in Drug Delivery (PODD) conference. Robert Hidalgo, VP of Operations, delivered a presentation highlighting the transformative potential of the company’s technology to revolutionize the patient experience.
PODD, a premier event for the pharmaceutical and drug delivery industries, provided an ideal platform for Portal Instruments to showcase its cutting-edge technology to key stakeholders and potential partners. Hidalgo’s presentation emphasized the significant challenges associated with traditional needle-based injections, including viscosity challenges, patient anxiety and environmental waste. Portal’s platform offers a compelling solution, aiming to eliminate these issues and significantly enhance the patient experience.
"Our electro-mechanical platform is designed to address the significant unmet needs in injectable drug delivery and solve the challenges of delivering high viscosity drugs while also taking care of the patient and the planet," said Robert Hidalgo
The PODD conference offered a valuable opportunity for Portal Instruments to connect with potential partners in the pharmaceutical and biotech sectors.
May 9, 2022 - Gerresheimer AG, a leading provider of drug delivery systems, is expanding its portfolio of highly innovative platform technologies for drug delivery, today announcing an investment into US-based Portal Instruments.
October 2019 - Drug development is a costly, long, and uncertain endeavor. The cost of taking a drug from preclinical research through market approval is $2.6 billion according to a recent study by the Tufts Center for the Study of Drug Development.
July 2020 - Portal Instruments has been selected as a finalist for the 2020 New England Innovation Awards. The Massachusetts Innovation Network is pleased to announce the 25 finalists of the Annual New England Innovation Awards, the oldest and longest-running innovation program in New England.
Please fill out the details below and we will get back to you shortly.